Article Outline

Article Information

PubMed

Related Articles

  • …more

Copyright © 2007 The Biophysical Society. All rights reserved.
Biophysical Journal, Volume 92, Issue 11, 3885-3892, 1 June 2007

doi:10.1529/biophysj.106.098889

Channels, Receptors, and Electrical Signaling

The Intracellular Domain of the β2 Subunit Modulates the Gating of Cardiac Nav1.5 Channels

Thomas ZimmerGo To Corresponding Author  and Klaus Benndorf

Institute of Physiology II, Friedrich Schiller University, Jena, Germany

Address reprint requests to Thomas Zimmer, PhD, Institute of Physiology II, Friedrich Schiller University Kollegiengasse 9, 07743 Jena, Germany. Tel.: 49-3641-934372; Fax: 49-3641-933202.

Abstract

We have previously shown that the transmembrane segment plus either the extracellular or intracellular domain of the β1 subunit are required to modify cardiac Nav1.5 channels. In this study, we coexpressed the intracellular domain of the β2 subunit in a β1/β2 chimera with Nav1.5 channels in Xenopus oocytes and obtained an atypical recovery behavior of Nav1.5 channels not reported before for other Na+ channels: Recovery times of up to 20ms at −120mV produced a similar fast recovery as observed for Nav1.5/β1 channels, but the current amplitude decreased again at longer recovery times and reached a steady-state level after 1–2s with current amplitudes of only 43±2% of the value at 20ms. Current reduction was accompanied by slowed inactivation and by a shift of steady-state activation toward depolarized potentials by 9mV. All effects were reversible and they were not seen when deleting the β2 intracellular domain. These results describe the first functional effects of a β2 subunit region on Nav1.5 channels and suggest a novel closed state in cardiac Na+ channels accessible at hyperpolarized potentials.

Introduction

The α-subunits of mammalian voltage-gated Na+ channels constitute a family of 10 different members 1 that are responsible for the initiation and propagation of action potentials in electrically excitable cells 2. These subunits interact with one or two small accessory β-subunits, thereby forming heteromultimeric protein complexes in the plasma membrane. As demonstrated by heterologous expression experiments, the α-subunit determines the main electrophysiological and pharmacological properties of a given Na+ channel 2. Functional analysis on the known β-subunits revealed their multifunctional nature: first, β1 and β3 subunits shift steady-state gating, accelerate Na+ current decay kinetics and recovery from inactivation, and increase the current amplitude of several α-subunits 3,4,5,6,7,8,9,10,11,12,13,14,15,16,17. The β1-induced gating effects on α-subunits strongly depend on the degree of sialylation of the extracellular β1 domain 18. Second, β1 subunits are capable of interfering with the action of fatty acids 19, pharmaceuticals 20, or natural toxins 21 on α-subunits. Third, β-subunits contain extracellular immunoglobulin (Ig) domains that are structurally homologous to the V-set of the Ig superfamily 22. They can act as cell adhesion molecules (CAM) 23 and recruit via intracellular interactions cytoskeletal proteins, such as ankyrin, to points of cell-cell contact 24. Thus, β-subunits serve as important communication links between the extracellular and intracellular environment of neurons. The conclusions from these in vitro studies were strongly supported by recent data on β1(−/−) and β2(−/−) knock-out mice 25,26,27. These experiments demonstrated not only the significance of both β-subunits for regulation of neuronal Na+ channel density and localization, but also the fundamental function of β1 for nodal architecture and neurite outgrowth, thus pointing to the in vivo action of accessory β-subunits as CAM in the central and peripheral nerve system.

In the mammalian heart, the Na+ channel isoform Nav1.5 dominates the INa in atrial and ventricular cardiomyocytes 1,28. Studies on the subunit composition of cardiac Na+ channels suggested an in vivo association of Nav1.5 with β1 and β2 subunits 29. Immunocytochemical studies further demonstrated a remarkable cardiac expression of both β-subunits by Western blotting 29,30, and suggested a preferential colocalization of Nav1.5 channels with β2 instead of β1 subunits at intercalated disks of ventricular cardiomyocytes 31. However, electrophysiological measurements in mammalian cell lines or Xenopus oocytes showed that only the β1 but not the β2 subunit exerts modulatory effects on Nav1.5 gating 15,29. Thus, the lack of any electrophysiological effect of β2 on Nav1.5 channels conflicts with the immunocytochemical data. A possible explanation could be that, in contrast to the situation in native cardiomyocytes, Nav1.5 does not associate with β2 upon heterologous expression, as concluded from a missing colocalization of respectively labeled subunit constructs 32.

We observed previously that the β1 transmembrane segment was required for a current increase and for an accelerated recovery from inactivation of Nav1.5 channels 15. To exert β1-like effects on Nav1.5, either the extracellular or the intracellular domain of the β1 subunit was necessary in addition to the short membrane spanning region. For example, deletion of the β1 intracellular domain (β11Δ) resulted in a faster recovery from inactivation and produced larger whole-cell currents, indicating that this shortened β1 variant still efficiently interacts with Nav1.5. In contrast, modulatory effects of the β2 subunit on Nav1.5 are unknown. To create a functional channel complex in which the β2 intracellular domain is in close contact with Nav1.5, we attached this β2 sequence to β11Δ resulting in β112. We expected that possible functional effects of the β2 intracellular domain may become visible when the spatial requirements for an α/β2 interaction are fulfilled. In this study, we used such a β-subunit construct and observed severe modulation of Nav1.5 function during recovery from inactivation that has not been observed in voltage-gated Na+ channels before.


Materials and methods

cDNAs of Na+ channel subunits

Plasmids pSP64T-hH1, pNa200, and pSPNaβ coding for human Nav1.5 (hH1, accession No. M77235), for Nav1.2 (rat brain IIA Na+ channel, accession No. X61149), and for the rat β1 subunit (accession No. M91808) were kindly provided by Dr. A. L. George (Vanderbilt University), Dr. A. L. Goldin (University of California), and Dr. W. Stühmer (Max Planck Institute, Göttingen), respectively. The β2 subunit (accession No. U37026) was isolated by RT-PCR from the human brain astrocytoma cell line 1321N1, as previously described 32. The isolation of sequences for mouse Nav1.4 (mH2; accession No. AJ278787) and mouse Nav1.5 (mH1; accession No. AJ271477) has been previously described 33.


Recombinant DNA procedures

We subcloned the cDNAs of the β1 and β2 subunit, and of deletion variant β11Δ into the in vitro transcription vector pGEMHEnew, resulting in plasmids pGEM-β1, pGEM-β2, and pGEM-β11Δ, as previously described 15. This vector contains the T7 promoter, a 5′-untranslated region (UTR) of the Xenopus β-globin gene and a multicloning site. To create the construct β112, the desired β1 and β2 subunit regions were first separately amplified by PCR and then linked by a recombinant PCR step using the internal primer pair 5′-ACTTGACCACCATCTCCGCCACGAGCCATA-3′ and 5′-GGCGGAGATGGTGGTCAAGTGTGTGAGGAG-3′. The recombinant fragment was subcloned into the BamHI/HindIII sites of pGEMHEnew resulting in pGEM-β112. PfuTurbo DNA polymerase (Stratagene, La Jolla, CA) was used for all PCR reactions to minimize PCR-mediated nucleotide exchanges. The plasmid was expected to encode chimera β112 consisting of amino acids M1–M178 of β1 plus amino acids V179–K215 of β2 (amino acid numbering according to the premature full-length proteins). Mouse Nav1.4 was subcloned into pSP64T by releasing the hH1 coding region in pSP64T-hH1 using BglII/SmaI digestion and inserting a BamHI/XhoI fragment of mouse Nav1.4 (mH2) released from the respective pTSV40Gnew vector 33, resulting in plasmid pSP64T-mNav1.4. To allow for a respective blunt-end ligation, the XhoI site was treated with Klenow enzyme. Mouse Nav1.5 was subcloned into a pSP64-PolyA derivative (Promega, Mannheim, Germany) by releasing the β1 subunit region in pSPNaβ using HindIII/HincII digestion and inserting a HindIII/NotI fragment of mouse Nav1.5 (mH1) released from pTSV40Gnew-mH1 33 after treatment of the NotI site with Klenow enzyme, resulting in vector pSP-mNav1.5. The correctness of the DNA constructs was checked by the dideoxy DNA sequencing method.


Heterologous expression in Xenopus oocytes

Capped cRNAs were prepared by digestion of respective plasmids with NotI (pNa200 and pSP64T-mNav1.4), EcoRI (pSP-mNav1.5), SpeI (pSP64T-hH1), XbaI (pGEM-β1 and pGEM-β11Δ), and HindIII (pGEM-β112 and pGEM-β2), followed by in vitro transcription reaction with SP6 (pSP64 derivatives) and T7 (pNa200 and all pGEM derivatives) RNA polymerase (Roche Diagnostics GmbH, Mannheim, Germany). Thus, the cRNAs of all Na+ channel isoforms and of the β-subunit variants were composed of the β-globin 5′-UTR and the respective α- or β-subunit sequence.

Oocytes from Xenopus laevis were obtained as previously described 32. Glass micropipettes were used to inject a volume of capped cRNA per oocyte of ∼40–60 nl. The final cRNA concentrations used to inject oocytes were 0.02μg/μl (Nav1.5) and 0.01μg/μl (Nav1.2, Nav1.4). The different cRNAs encoding the β-subunit variants were at a concentration of ∼0.1μg/μl so that the final molar ratio of α- to β-subunit was ∼1:50 at the cRNA level. Injected oocytes were incubated for 3 days at 18°C in Barth medium. Under those conditions the amplitudes of INa, measured 3 days after injection at the test potential of -25mV (Nav1.5) and −10mV (Nav1.2, Nav1.4), were between 0.5 and 5.0μA. The recovery from inactivation was determined from Na+ currents with an amplitude between 1 and 4μA.


Electrophysiology

Whole-cell Na+ currents were recorded with the two-microelectrode voltage clamp technique using a commercial amplifier (OC725C, Warner Instruments, Hamden, CT). The glass microelectrodes were filled with 3M KCl. The microelectrode resistance was between 0.2 and 0.5 MΩ. The bath solution contained (in mM): 96 NaCl, 2 KCl, 1.8 CaCl2, 10 Hepes/KOH, pH 7.2. The currents were elicited by test potentials from −80 to 40mV (holding potential of −120mV). The pulsing frequency was 0.1Hz. We used only cells that produced a peak current amplitude <5μA. Steady-state activation (m) was evaluated by fitting the Boltzmann equation m={1+exp[−(VVm)/s]}−1 to the normalized conductance as function of voltage. V is the test potential, Vm the midactivation potential, and s the slope factor in mV. Recovery from inactivation was determined with a standard protocol (Fig. 1) at a frequency of 0.1Hz. Recording and analysis of the data were performed on a PC with the ISO2 software (MFK, Niedernhausen, Germany). The sampling rate was generally 20kHz.

Display large version of this figure
Figure 1
Atypical recovery from inactivation in Nav1.5 channels produced by the intracellular domain of the β2 subunit in β112. The figure illustrates the domain structures of β1, β11Δ, and β112, and the corresponding Nav1.5 current traces at the indicated recovery intervals. The respective terminal amino acids of the β1 (black) and β2 (gray) subunit regions are indicated. We observed an accelerated recovery process and a current increase when coexpressing wild-type β1 subunit or deletion variant β11Δ. Recovery time constants τrec determined with monoexponential fits were (in ms): 5.87±0.18 for Nav1.5, 3.20±0.13 for Nav1.5/β1, and 3.95±0.29 for Nav1.5/β11Δ (n=8–15). Peak-current amplitudes relative to Nav1.5 increased significantly by factor 3.47±0.32 (β1) and 1.33±0.15 (β11Δ). Attachment of the β2 intracellular domain to the β1 transmembrane segment produced a paradoxical recovery behavior of wild-type Nav1.5 channels. The pulse protocol is illustrated (pulse frequency 0.1Hz). Calibration bars: 20ms and 0.5μA.


Results

To test for a possible effect of the intracellular domain of the β2 subunit on Nav1.5, we attached this domain to the transmembrane plus extracellular domain of β1, resulting in chimera β112. We coexpressed the chimera with Nav1.5 channels in Xenopus oocytes and investigated whole-cell currents by the two-microelectrode voltage-clamp technique. Coexpression of chimera β112 produced an Nav1.5 recovery behavior that was not seen before in any other voltage-gated Na+ channel (Fig. 1, bottom): Short recovery intervals up to ∼20ms allowed Nav1.5 channels to recover efficiently from inactivation resulting in increased current amplitudes. This process occurred almost as fast as in the case of Nav1.5/β1 channels (Figure 2A, right) and should be therefore mediated by β1 regions in chimera β112. Longer recovery intervals, however, led to a paradoxical decrease of the current (Fig. 1, bottom). After ∼1s, a steady-state current level with an amplitude of 43±2% of the value at 20ms was reached (Figure 2A, left). We observed this atypical recovery in both mouse and human Nav1.5 channels coexpressed with β112, but neither in Nav1.2 nor in Nav1.4 channels: Coexpression of β112 with the neuronal or skeletal muscle isoform produced typical β1-like effects, as accelerated recovery from inactivation (Figure 2BC), increased current densities, and faster inactivation (data not shown). In conclusion, a close contact of cardiac-specific Nav1.5 with the β2 intracellular domain led to a distinct interaction of both proteins, producing an atypical recovery from inactivation.

Display large version of this figure
Figure 2
Recovery from inactivation in mouse Nav1.5 (A), rat Nav1.2 (B), and mouse Nav1.4 (C) channels upon coexpression of β112. The figure shows that Nav1.5/β112 currents decreased at recovery intervals >20ms and reached a steady-state level after 1–2s with current amplitudes of <50% of the value at 20ms. In case of human Nav1.5 very similar data were consistently obtained (data not shown). In Nav1.2 and Nav1.4 channels, an atypical recovery was not observed. Instead, the typical β1-like modulatory effect on recovery was obtained when coexpressing β112. Number of measurements: n=9 for Nav1.5, n=15 for Nav1.5/β1, n=15 for Nav1.5/β112, n=7 for Nav1.2, n=6 for Nav1.2/β1, n=6 for Nav1.2/β112, n=9 for Nav1.4, n=5 for Nav1.4/β1, and n=6 for Nav1.4/β112. For pulse protocol see Fig. 1 (test pulse to −30mV for Nav1.5, and to −20mV for Nav1.2 and Nav1.4). Error bars represent mean±SE.

To exclude that an irreversible “run-down” caused the time-dependent current decrease at hyperpolarized potentials, we successively prolonged the recovery intervals Δt from 1ms to 7s, and shortened the time periods again from 7s to 1ms using the same oocyte. We found that the atypical recovery was reversible (Fig. 3).

Display large version of this figure
Figure 3
The atypical recovery in Nav1.5/β112 channels was reversible. The recovery interval Δt was successively prolonged until 7s (■) and then again shortened to 1ms (○). The figure illustrates fractional recovery at intervals up to 7s (left) and up to 300ms (right). For pulse protocol see Fig. 1 (n=6). Error bars represent mean±SE.

We next investigated whether Nav1.5 inactivation kinetics were affected by β112 (Fig. 4). After a recovery interval of 15ms, inactivation time constants τh were similar for Nav1.5, Nav1.5/β1, and Nav1.5/β112 channels (e.g., τh in ms at −25mV: 2.05±0.14 for Nav1.5, 2.04±0.08 for Nav1.5/β1, and 2.17±0.17 for Nav1.5/β112; n=5). At the same time, current amplitudes were significantly larger when coexpressing either β1 or β112, compared to cells expressing Nav1.5 alone (Figure 5A). This current increase is mediated by the extracellular domain and the transmembrane segment of β1, because it was also found when coexpressing β11Δ 15. Upon longer recovery intervals, the β2 intracellular domain successively decreased the current amplitude and concomitantly decelerated the inactivation kinetics (Figure 4B and Figure 5B). Interestingly, a minor deceleration of inactivation upon longer recovery intervals occurred also in Nav1.5 and Nav1.5/β1 channels (Fig. 4).

Display large version of this figure
Figure 4
Effect of β112 on inactivation kinetics of Nav1.5 channels. Current traces from Nav1.5, Nav1.5/β1, and Nav1.5/β112 channels at −25mV, and corresponding plots of the inactivation time constants τh as function of voltage after recovery intervals of 15ms (■) and 4000ms (○). Please note that a significant deceleration of inactivation upon longer recovery intervals occurred also in Nav1.5 and Nav1.5/β1 channels (p<0.05 for τh values in ms at −10mV: 1.29±0.05 at 15ms versus 1.70±0.08 at 4000ms for Nav1.5, and 1.18±0.07 at 15ms versus 1.72±0.04 at 4000ms for Nav1.5/β1). Calibration bar is: 5ms, and 0.9μA for Nav1.5, 1.9μA for Nav1.5/β1, 1.0μA for Nav1.5/β112 at 15ms, and 0.3μA for Nav1.5/β112 at 4000ms. Number of experiments is: n=6 for Nav1.5, n=5 for Nav1.5/β1, and n=5 for Nav1.5/β112. Error bars represent mean±SE.
Display large version of this figure
Figure 5
Effect of the β2 intracellular domain on current amplitude and inactivation time constants in Nav1.5 channels. (A) Current amplitudes at recovery intervals Δt of 15 and 1000ms (n=5 each). At Δt=15ms, the modulatory effect of the β1 region on Nav1.5 current amplitude can be observed also when coexpressing β112 (* indicates p<0.05 versus Nav1.5 at 15ms). However, at longer recovery intervals currents through Nav1.5/β112 channels decreased successively (compare also Fig. 1 to Fig. 3). (B) Current amplitude as a function of the inactivation time constant τh in Nav1.5/β112. The decreased current amplitudes upon longer recovery intervals are accompanied by decelerated inactivation. Data points were obtained from five independent measurements (illustrated by the five different symbols). The increase of τh was caused by successively prolonging the recovery interval (15, 50, 100, 300, 500, and 1000ms; recovery potential, −120mV).

These data suggested that, upon interaction with the β2 intracellular domain, Nav1.5 channels enter an additional closed state at hyperpolarized potentials in a time-dependent manner. As shown in Fig. 6, Nav1.5/β112 channels captured in this closed state (−120mV for 10s) could not escape when stepping the voltage of the prepulse up to −80mV: The currents at the test pulse were constant at nearly 30% of the maximal current. Further prepulse depolarizations allowed for a transition to the open and/or inactivated state during this prepulse. During the recovery pulse of 15ms at −120mV, channels recovered from inactivation. This interval was too short for a full transition to the additional closed state. Consequently, channel activation at the test pulse was facilitated and currents increased. Such an atypical recovery behavior was not observed in Nav1.5/β1 channels: The 15-ms recovery interval was too short for a complete recovery of channels that were inactivated during the prepulse. Consequently, the current at the test pulse decreased (Fig. 6).

Display large version of this figure
Figure 6
Effect of the prepulse potential on recovery of Nav1.5/β112 channels at a short recovery interval (15ms). The figure illustrates the relative current amplitude (normalized to −1) at the test pulse (−30mV) as a function of the prepulse potential (from −120 to +20mV). Number of measurements, n=7 each. Error bars represent mean±SE.

Reduced whole-cell currents and slowed inactivation in Nav1.5/β112 channels at longer recovery intervals suggested that the current decrease during the recovery from inactivation is at least to some extent the result of a shift of steady-state activation toward depolarized potentials. To test this hypothesis, we compared steady-state activation curves at the recovery intervals of 15 and 4000ms. At 15ms, we obtained similar midactivation potentials (Vm) for Nav1.5, Nav1.5/β1, and Nav1.5/β112 channels (Table 1). At 4000ms, Vm values did not change in case of Nav1.5 and Nav1.5/β1 channels (p>0.05). In contrast, chimera β112 significantly shifted Nav1.5 steady-state activation by ∼9mV to depolarized potentials (15 vs. 4000ms; Table 1, Fig. 7). This shift can fully explain the observed whole-cell current reduction during recovery from inactivation. When applying a test pulse around the midactivation potential (−30mV), the respective depolarized shift of the steady-state activation curve decreased the channel number responding to the voltage stimulus. Consequently, the phenomenon of reduced peak currents upon longer recovery intervals was not seen when applying a test pulse to 0mV (Figure 7C). However, the altered steady-state activation alone cannot explain the significantly decelerated inactivation kinetics in Nav1.5/β112 channels. Current decay time constant remained markedly larger also at test potentials more positive than 0mV (Fig. 4).

Display large version of this figure
Longer recovery intervals shift steady-state activation in Nav1.5/β112 channels. (A) Currents of Nav1.5/β112 channels measured after the indicated recovery time points. (B) Representative steady-state activation curves in Nav1.5/β112 channels for recovery intervals of 15ms (■) and 4000ms (○). For midactivation potentials (Vm) and statistics, see Table 1. (C) Recovery from inactivation in Nav1.5/β112 channels at test potentials of 0 vs. −30mV. Peak current reduction at −30mV depended on the shift of the steady-state activation curve. At 0mV, all available channels are activated and consequently, a current reduction was not obtained. Number of measurements, n=5. All values were normalized with respect to the maximum current obtained at −30mV.

Finally, we investigated the voltage dependence of the atypical recovery and compared the effect of two distant recovery potentials (−80 and −140mV). As shown in Figure 8A (left), we observed a much faster initial recovery at −140mV compared to −80mV. In control experiments with Nav1.5/β1 channels, recovery was much faster at the more hyperpolarized potential (Figure 8A, right) and both recovery potentials produced the maximal steady-state current level. In contrast to this, availability of Nav1.5/β112 channels passed a maximum and reached finally a steady-state value at ∼30% of the maximal current. Interestingly, this steady state was independent of the recovery potential: We observed a similar steady-state level at both −140 and −80mV. Consequently, when investigating the effect of the β2 intracellular domain in β112 on both Nav1.5 inactivation time course and steady-state activation, we obtained similar data for both potentials at long recovery intervals (Figure 8BC). Therefore, we conclude that the channel transition to the additional closed state at potentials negative to −80mV is voltage independent.

Display large version of this figure
Figure 8
Atypical recovery from inactivation in Nav1.5/β112 channels at recovery potentials of −140 and −80mV. (A) Recovery from inactivation in Nav1.5/β112 (left) and Nav1.5/β1 (right) channels. Shorter intervals led to a faster recovery at the more hyperpolarized potential in both Nav1.5/β112 and Nav1.5/β1 channels. In contrast to Nav1.5/β1, atypical recovery occurred in Nav1.5/β112 at both −140 and −80mV, resulting in similar current levels at intervals >0.3s independently of the recovery potential. (B) Effect of the β2 intracellular domain on Nav1.5 steady-state activation after long recovery intervals. A clear shift of steady-state activation occurred at −140mV after longer recovery intervals (* p<0.05; midactivation potentials Vm, −31.1±1.8mV at 15ms versus −23.9±1.9mV at 4000ms), similarly as observed at −120mV (see Table 1). At 4000ms, steady-state activation was similar at −80mV (Vm, −22.8±1.7mV; n=16) compared to −140mV. Neither the recovery interval nor the recovery potential had an effect on Nav1.5/β1 channels (at −140mV, Vm=−30.2±1.6 at 15ms and −30.3±2.0 at 4000ms; at −80mV, Vm=−28.9±1.5mV at 4000ms; n=11). (C) Inactivation time constant τh as function of voltage at a recovery interval of 4000ms. Deceleration of inactivation occurred only in Nav1.5/β112 and did not depend on the recovery potential (n=16 for Nav1.5/β112, n=11 for Nav1.5/β1). Error bars represent mean±SE.

Discussion

In this study we report the first functional effects of a specific β2 sequence on cardiac Nav1.5 channels: The β2 intracellular domain is capable of generating an atypical recovery behavior of cardiac Nav1.5 channels. At longer recovery intervals the β2 intracellular domain shifted steady-state activation toward depolarized potentials and decelerated channel inactivation (Figure 4 and Figure 7). Thus, the paradoxical current decrease upon longer recovery intervals observed at test potentials negative to −10mV (e.g., −30mV in Fig. 1) is not simply caused by an overshooting recovery from inactivation, as observed previously in voltage-gated K+ channels 34. Our data suggest the existence of a novel closed state in Nav1.5 channels accessible at hyperpolarized potentials that does neither occur in neuronal Nav1.2 nor in skeletal muscle Nav1.4 channels.

How can we interpret our results in terms of an Nav1.5 gating model? We suggest that at hyperpolarized voltages, channels switch rapidly from the inactivated to the normal closed state in a voltage-dependent manner. This process is largely complete within 15–30ms. After these short recovery intervals, channel activation produced current amplitudes and inactivation kinetics that were similar to those seen for Nav1.5/β1 channels (see increased current amplitudes upon coexpression of either β1 or β112 in Figure 5A). Prolongation of the recovery interval, however, favors a transition to an additional closed state, until a steady state is reached (after ∼1s). This transition is voltage independent at potentials negative to −80mV (see Fig. 8). Channel activation from this additional closed state requires more positive voltages. At the same time, inactivation kinetics are decelerated. In conclusion, our data indicate that Nav1.5 channels can be inactivated also by hyperpolarization. Inactivation kinetics have been demonstrated more than 20 years ago to be caused by the first latency of the channels 35. Single-channel analysis would be required to define the contribution of a possibly altered first latency to the biophysical phenomenon observed with Nav1.5/β112 channels. Significantly larger inactivation time constants at test pulse potentials positive to 0mV suggest that also other single-channel properties are altered by β112: A test pulse to 0mV increased whole-cell currents and decelerated inactivation kinetics upon longer recovery intervals (compare Figure 4C and Figure 7C). It is interesting to note that a small Nav1.5 channel fraction obviously enters the additional closed state also when coexpressing β1 or even in the absence of any other subunit (see decelerated inactivation at recovery interval of 4000ms; left and middle panel in Fig. 4).

Although we measured currents through wild-type Na+ channels, we used an artificial construct to provoke the unusual Nav1.5 gating phenomenon. Consequently, our data raise the question why such an atypical recovery has not yet been observed when coexpressing wild-type β2? Previously, we found that Nav1.5 and β2 are not colocalized upon heterologous expression 32, in contrast to immunocytochemical data obtained in cardiomyocytes 31. However, missing colocalization is incompatible with an efficient intracellular assembly and trafficking of the channel complex to the plasma membrane, and thus also with a modulatory action of, respectively, associated β-subunits 15,32. When anchoring the intracellular domain of the β2 subunit to a β1 subunit deletion variant that interacts with Nav1.5 (β11Δ; 15), we reconstituted a channel complex in which the β2 sequence should interact with Nav1.5. In respective control experiments, we investigated the subcellular localization of Nav1.5/β11Δ and Nav1.5/β112 channels using different variants of the green fluorescent protein, and we indeed observed a strict α/β colocalization that was not seen when using wild-type β2 (data not shown).

However, we have to consider that the β2 intracellular domain may not interact at the correct β2 binding site in Nav1.5 when using chimera β112. It is imaginable that β1 and β2 normally bind distinct sites on α-subunits. Thus, it is possible that chimera β112 binds specifically at the β1 site, thereby directing the β2 intracellular domain to Nav1.5 regions normally interacting with β1. Moreover, protein folding of the intracellular domain of β2 may be affected in the chimera, despite an obviously normal trafficking and correct localization in the plasma membrane of heterologous host cells. Consequently, the paradoxical recovery effect could be rather specific for the chimera and may not be produced in vivo by wild-type β2. The fact that the recovery behavior reported in this study has not been seen in native cardiac Na+ channels before is consistent with this idea 36.

In conclusion, the results of our study provide more insight into the biophysical properties of wild-type Nav1.5 channels by suggesting the existence of an additional closed state at hyperpolarized potentials that has not been detected so far. This state does neither exist in neuronal nor skeletal muscle Na+ channels, providing further evidence for the unique feature of Nav1.5 to interact with β-subunits also at intracellular regions. Further research is necessary to provide more insight into the nature of this additional closed state by identifying the interacting amino acid residues in Nav1.5. At the same time we have to notice that conclusions on the physiological significance of our results for an in vivo Nav1.5/β2 interaction in the heart are still strictly limited.


Acknowledgments

Note added in proof: Recently, Johnson and Bennett 37 reported a β2-mediated hyperpolarizing shift in Nav1.5 gating that was dependent on the degree of protein sialylation. This novel effect of β2 on Nav1.5 function is, however, mediated by the extracellular domains of the channel subunits and thus distinct from the recovery effect reported in the present study.

The authors thank Karin Schoknecht and Birgit Tietsch for excellent technical assistance.

This work was supported by the German Federal Ministry of Education and Research grant 01ZZ0105 IZKF Jena (project 4.12) to T.Z.

References

1. Goldin, A.L. (2001). Resurgence of sodium channel research. Annu. Rev. Physiol. 63, 871–894. CrossRef | PubMed

2. Catterall, W.A. (1992). Cellular and molecular biology of voltage-gated sodium channels. Physiol. Rev. 72, S15–S48. PubMed

3. Wallner, M., Weigl, L., Meera, P., and Lotan, I. (1993). Modulation of the skeletal muscle sodium channel α-subunit by the β1-subunit. FEBS Lett. 336, 535–539. CrossRef | PubMed

4. Makita, N., Bennett, P.B., and George, A.L. (1994). Voltage-gated Na+ channel β1 subunit mRNA expressed in adult human skeletal muscle, heart, and brain is encoded by a single gene. J. Biol. Chem. 269, 7571–7578. PubMed

5. Patton, D.E., Isom, L.L., Catterall, W.A., and Goldin, A.L. (1994). The adult rat brain β1 subunit modifies activation and inactivation gating of multiple sodium channel α-subunits. J. Biol. Chem. 269, 17649–17655. PubMed

6. Nuss, H.B., Chiamvimonvat, N., Perez-Garcia, M.T., Tomaselli, G.F., and Marban, E. (1995). Functional association of the β1 subunit with human cardiac (hH1) and rat skeletal muscle (μ1) sodium channel α subunits expressed in Xenopus oocytes. J. Gen. Physiol. 106, 1171–1191. CrossRef | PubMed

7. Qu, Y., Isom, L.L., Westenbroek, R.E., Rogers, J.C., Tanada, T.N., McCormick, K.A., Scheuer, T., and Catterall, W.A. (1995). Modulation of cardiac Na+ channel expression in Xenopus oocytes by β1 subunits. J. Biol. Chem. 270, 25696–25701. CrossRef | PubMed

8. Kupershmidt, S., Yang, T., and Roden, T.M. (1998). Modulation of cardiac Na+ current phenotype by β1-subunit expression. Circ. Res. 83, 441–447. PubMed

9. Smith, R.D., and Goldin, A.L. (1998). Functional analysis of the rat I sodium channel in Xenopus oocytes. J. Neurosci. 18, 811–820. PubMed

10. Morgan, K., Stevens, E.B., Shah, B., Cox, P.J., Dixon, A.K., Lee, K., Pinnock, R.D., Hughes, J., Richardson, P.J., Mizuguchi, K., et al. (2000). β3: An additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc. Natl. Acad. Sci. USA 97, 2308–2313. CrossRef | PubMed

11. Qu, Y., Curtis, R., Lawson, D., Gilbride, K., Ge, P., DiStefano, P.S., Silos-Santiago, I., Catterall, W.A., and Scheuer, T. (2001). Differential modulation of sodium channel gating and persistent sodium currents by the β1, β2, and β3 subunits. Mol. Cell. Neurosci. 18, 570–580. CrossRef | PubMed

12. Shah, B.S., Stevens, E.B., Pinnock, R.D., Dixon, A.K., and Lee, K. (2001). Developmental expression of the novel voltage-gated sodium channel auxiliary subunit β3, in rat CNS. J. Physiol. 534, 763–776. CrossRef | PubMed

13. Stevens, E.B., Cox, P.J., Shah, B.S., Dixon, A.K., Richardson, P.J., Pinnock, R.D., and Lee, K. (2001). Tissue distribution and functional expression of the human voltage-gated sodium channel β3 subunit. Pflugers Arch. 441, 481–488. CrossRef | PubMed

14. Meadows, L.S., Chen, Y.H., Powell, A.J., Clare, J.J., and Ragsdale, D.S. (2002). Functional modulation of human brain Nav1.3 sodium channels, expressed in mammalian cells, by auxiliary beta1, beta2 and beta3 subunits. Neuroscience 1144, 745–753. PubMed

15. Zimmer, T., and Benndorf, K. (2002). The human heart and rat brain IIA Na+ channels interact with different molecular regions of the β1 Subunit. J. Gen. Physiol. 120, 887–895. CrossRef | PubMed

16. Vijayaragavan, K., Powell, A.J., Kinghorn, I.J., and Chahine, M. (2004). Role of auxiliary beta1-beta2-, and beta3-subunits and their interaction with Nav1.8 voltage-gated sodium channel. Biochem. Biophys. Res. Commun. 319, 531–540. CrossRef | PubMed

17. Ko, S.-H., Lenkowski, P.W., Lee, H.C., Mounsey, J.P., and Patel, M.K. (2005). Modulation of Nav1.5 by β1- and β3-subunit co-expression in mammalian cells. Pflugers Arch. 449, 403–412. CrossRef | PubMed

18. Johnson, D., Montpetit, M.L., Stocker, P.J., and Bennett, E.S. (2004). The sialic acid component of the β1 subunit modulates voltage-gated sodium channel function. J. Biol. Chem. 279, 44303–44310. CrossRef | PubMed

19. Xiao, Y.-F., Wright, S.N., Wang, G.K., Morgan, J.P., and Leaf, A. (2000). Coexpression with β1-subunit modifies the kinetics and fatty acid block of hH1α Na+ channels. Am. J. Physiol. Heart Circ. Physiol. 279, H35–H46. PubMed

20. Makielski, J.C., Limberis, J.T., Chang, S.Y., Fan, Z., and Kyle, J.W. (1996). Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block. Mol. Pharmacol. 49, 30–39. PubMed

21. Messner, D.J., and Catterall, W.A. (1986). The sodium channel from rat brain. Role of the β1 and β2 subunits in saxitoxin binding. J. Biol. Chem. 261, 211–215. PubMed

22. Isom, L.L., Ragsdale, D.S., De Jongh, K.S., Westenbroek, R.E., Reber, B.F.X., Scheuer, T., and Catterall, W.A. (1995). Structure and function of the β2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell 83, 433–442. Abstract | | CrossRef | PubMed

23. Ratcliffe, C.F., Westenbroek, R.E., Curtis, R., and Catterall, W.A. (2001). Sodium channel β1 and β3 subunits associate with neurofascin through their extracellular immunoglobulin-like domain. J. Cell Biol. 154, 427–434. CrossRef | PubMed

24. Malhotra, J.D., Kazen-Gillespie, K., Hortsch, M., and Isom, L.L. (2000). Sodium channel β subunits mediate homophilic cell adhesion and recruit ankyrin to points of cell-cell contact. J. Biol. Chem. 275, 11383–11388. CrossRef | PubMed

25. Chen, C., Bharucha, V., Chen, Y., Westenbroek, R.E., Brown, A., Malhotra, J.D., Jones, D., Avery, C., Gillespie, P.J., Kazen-Gillespie, K.A., et al. (2002). Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc. Natl. Acad. Sci. USA 99, 17072–17077. CrossRef | PubMed

26. Chen, C., Westenbroek, R.E., Xu, X., Edwards, C.A., Sorenson, D.R., Chen, Y., McEwen, D.P., O’Malley, H.A., Bharucha, V., Meadows, L.S., et al. (2004). Mice lacking sodium channel beta1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J. Neurosci. 24, 4030–4042. CrossRef | PubMed

27. Davis, T.H., Chen, C., and Isom, L.L. (2004). Sodium channel β1 subunits promote neurite outgrowth in cerebellar granule neurons. J. Biol. Chem. 279, 51424–51432. CrossRef | PubMed

28. Balser, J.R. (2001). The cardiac sodium channel: gating function and molecular pharmacology. J. Mol. Cell. Cardiol. 33, 599–613. CrossRef | PubMed

29. Malhotra, J.D., Chen, C., Rivolta, I., Abriel, H., Malhotra, R., Mattei, L.N., Brosius, F.C., Kass, R.S., and Isom, L.L. (2001). Characterization of sodium channel α- and β-subunits in rat and mouse cardiac myocytes. Circulation 103, 1303–1310. PubMed

30. Sutkowski, E.M., and Catterall, W.A. (1990). β1 subunits of sodium channels. Studies with subunit-specific antibodies. J. Biol. Chem. 265, 12393–12399. PubMed

31. Maier, S.K.G., Westenbroek, R.E., McCormick, K.A., Curtis, R., Scheuer, T., and Catterall, W.A. (2004). Distinct subcellular localization of different sodium channel α and β subunits in single ventricular myocytes from mouse heart. Circulation 109, 1421–1427. CrossRef | PubMed

32. Zimmer, T., Biskup, C., Bollensdorff, C., and Benndorf, K. (2002). The β1 subunit but not the β2 subunit colocalizes with the human heart Na+ channel (hH1) already within the endoplasmic reticulum. J. Membr. Biol. 186, 13–21. CrossRef | PubMed

33. Zimmer, T., Bollensdorff, C., Haufe, V., Birch-Hirschfeld, E., and Benndorf, K. (2002). Mouse heart Na+ channels: primary structure and function of two isoforms and alternatively spliced variants. Am. J. Physiol. Heart Circ. Physiol. 282, H1007–H1017. PubMed

34. Wettwer, E., Amos, G.J., Posival, H., and Ravens, R. (1994). Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ. Res. 75, 473–482. PubMed

35. Aldrich, R.W., Corey, D.P., and Stevens, C.F. (1983). A reinterpretation of mammalian sodium channel gating based on single channel recordings. Nature 306, 436–441. CrossRef | PubMed

36. Benndorf, K., and Nilius, B. (1987). Inactivation of sodium channels in isolated myocardial mouse cells. Eur. Biophys. J. 15, 117–127. PubMed

37. Johnson, D., and Bennett, E.S. (2006). Isoform-specific effects of the β2 subunit on voltage-gated sodium channel gaiting. J. Biol. Chem. 281, 25875–25881. CrossRef | PubMed

Publication Information


Received: October 4, 2006
Accepted: January 17, 2007